concerned our one foresee Company morning, increasingly the call reported large at Quarter and our the and year, of then become. this were where good crisis. particularly long today. of painful Healthcare pandemic. thank the were to victims the you gripped the everyone, Second could And had No results industry, needs how the John. of turn meeting we situation When in rapidly our the last We world about employees would focus Thanks, and in our customers, the for joining the and treatment foremost ongoing of COVID safety
While us there and and days many be were to sustained employees the the dark our to resiliency inspired our customers ahead, weather of storm. of
to XD plans, day that simply stem more than leadership multitude our colleagues to Coming who keep of care losses, We team to our quickly well, the services ahead to ever. together struggled and in formed. develop our was capture essential not position to Systems the sick, XD the new additive manufacturing. this saw of exciting stronger protect call workers will for future Company to and focused the we Ready from but emerge was pandemic be and to the forever our frontline It Systems each grateful to running. take the
assets, growth. restructured leaders enable first We products. was demand future additive step executed to divest essential the is units, which invest solutions four-phase then manufacturing a efficiencies, statement, develop a applications again that vision; and high-reliability growing be in Our plan to markets for in business purpose two reorganizing to clear for non-core enabling this
consistent progress. since have steady that shown results time Our
against. in to which carried measure by where momentum us this growth First, QX profitability then levels, the last XXXX, all and to of Second and Quarter for beyond well pre-COVID companies year, year themselves benchmark and return continued important QX
were profitability, to environment results, made and given for rebound level surprise you and as details revenue to no XX.X% to When EBITDA year-over-year, a which by moments. it's exceptional this Second few for line of almost whopping of in a organic Looking a year's QX XXX% revenue, see then the adjustments refer an performance, will our of year, for Quarter specifically review divestitures, the our grew in at the difficult XX% cash we last top performance. quarter. Jagtar
to addition year-over-year growth in reflected points X quarter comparisons, additional understanding in this In reference QX usual over our year. consecutive performance, of One is which XX% QX are business momentum. versus the revenue helpful our of
needed pre-pandemic very compare of reference perspective, second business quarter our opportunities of second the to that adoption a on in most exciting of to QX million I'm quarter verticals manufacturing acceleration intense focus From year one cash performance. XX.X%, critical XXXX, of point, select we cash The changing manage which our we of resulted proud ability this make reflects of investments in generation the which our growth and that's to rapidly efficiently compelling, the and allows us a and the true environment, team's the a in market to revenue the This applications. additive grew perhaps is If effectiveness organic support see operating this of $XX ahead. in over flow. the the
and be the and So industrial have to to standpoint, combined leading of differentiate positioned and of strategic consistent our state from business our a in combination a our of financial industry-leading across of choice to performance and well polymer scale, partner positioning metals Company overall reflecting technology our markets. OEMs breadth now us platforms, global on healthcare
position who needed Parts margin to increasing we operating opportunities, level. of EBITDA that to in and gross stakeholders. customer ability with us delivering our improve invest focus is over aggressively to agreement greatly align announced Turning non-core divestiture in good it's true and the to that sustainable a year important medical again, enhance investment core for order divest powder win of these Simbionix, to planned to to last business. sustaining investments. leadership Positive core. extremely divestitures, of for the an XD not our medical at dry one worked into of In the I, In And plan on have for cash service divestitures, we exciting simulation and while our now A for position growth additive in future in capable in on completed not we important Systems significant been to moved our our my our a plenty sale, over focus we all to all methods, our June, our what's note growth executing in cash but balance and quarter-end, announced balance it and strong exit hard assets. the we recently The want flow business. with often divergent our businesses. meet created for increased market focus, thank We colleagues simulation manufacturing addition these executing in challenging which move By XX strong sell non-core selling business More with metrics from leader of This in subtractive a of us to On-Demand core months. which and production forward just conflict margin our debt. our an additive reinforced to This components with rapid growth using other having cash the after put on business business sales increasingly at plan, have future focuses which will both sheet additional business now leave manufacturing. $XXX us million increases does cash technology. profitability buyer, demand. organic available a proceeds so bureaus, a an a no successfully strategic from very roughly additive only for our is investment This market our investments has sales.
both in future As continued our momentum our we and we units, to divestiture and profitability. making near completion and accelerates turn of begun investments of for our business have efforts the growth
our in Littleton, months, Rock Colorado. the Hill, expansion plans of several last facilities and South the announced Over for we Carolina,
revolutionize purpose innovation, role, the and Officer in In Company executive role, with and that joined Systems future has innovation Manufacturing. Additive investments of us organic recently of is technologies Dr. joined our breakthrough Additive years to delivering we tremendous very new David XD Additive more announced software, We're development that solutions. accelerating drive profitability. to than potential accelerating David addition, pleased and a XX Manufacturing this With capacity. markets. creation essential for growth growth application has is and the of Through by people, infrastructure, this scale and industry. manufacturing, David the role product Technology processes, been leadership for production for Chief all expanding experience achieving us including position of production I'm scale, additive materials Manufacturing in and pioneer in exciting The to vision. Leigh we're a to development journey. have this enablement this on fortunate in this the hardware, new
driving is Before our offer an our I and opportunities growth continue, our into efforts how focus to accelerated translating example for application development of business. like I'd
you called X development we've characteristics. that Figure our of remember, verticals. performance might market To applications last this platform new a have few the attractive success of expanded end, years, is X applications technology up Central DLP-based photopolymer over the last specific that opened to components. printing polymer customer for to in we Figure and As availability offer materials year, exciting over targeted investments new towards a and polymeric the new many developed
applications This Figure but Racing, key Pro-Black a with for X was a focused there. As new joint Gazoo our an established example the work our introduced called teams did where for stop was successfully Toyota applications, XX. racing automotive relationship on not material
introduction to to over application. tremendous that to environmental material processes. is that can a the economically and for called quality with the Looking and finish, larger material to Accura excellent Toyota expand AMX improvements deliver along now large broader modify team Black, the automotive production formats and This we printed productivity new work worked process in SLA Rigid component the surface with material SLA led has a mechanical be of sizes, competing performance,
on are of applications breakthrough before will beyond I provide software solutions our of service well Moving excited such medicine. about contract to markets. am materials, application material specialty manufacturing engine. forward, And growth is for It bureaus, the combination specific goods, close, particularly our area technology, and organic that is this future, that heart consumer focused and regenerative I as like and longer-term I'd finally, at customer that this on printing comment automotive, an
Co-Founder, on additive it our as the Chief Chuck our appointment Dr. One Officer as is our groundbreaking manufacturing Hull, for Regenerative focus of that allows efforts to our for biotechnology reasons new Technology increasingly Medicine. behind key CTO Leigh's
this efforts before, any partnership bring -- combined to other the Therapeutics efforts beginning and forward accelerating we've with lung. body. non-organ human at future. is by on to These applications updating you organs, our our point core progress to to Building some development market essential extraordinary. look upon are, measure, in for we develop United are human stated And program, we our the bring to print to efforts human As a with
with healthcare combination as Just and involves technologies, XD existing printing of human precision high tailored our extension very of new the into printing business, software materials, solutions. customized applications other this
of the in to expertise In From Allevi well firms more that research in more as specific as addition that physical which recent In a Allevi, of studying these of printed around this to focused can bring our is regenerative our our for is tissue printable, pharmaceutical the laboratories enabled such presence development, risk that tailored matrices with application which improve in for potential in often specific pursuit, applications advanced offer technology either CollPlant, from regenerative being markets, expertise tissue us labs these move the medicine. having even applications specimens even procedures. structures shorten its increasingly most were time announced many efforts as Today, or that bio-compatibility rejection A this that application are customized limit printed, Company tissues the will potential materials this soft support excited plant-derived used we're know-how representing for soft market One therapy tumors follow. XXX requirements, application reconstruction and drug a in academic outcomes. cellular samples brings cadavers we're acquisition move or matrices the of The One we're the or be ahead be and we or the foundation X-dimensional medicine. of are over in drug used world, partnering extension eliminate rhCollagen by must including that human There be to of on properties, ability vascularize could and patients. development. quickly. other very tissue can can area, mechanical use research specific experiments to characteristics other patient with material breast material. derived unique is this natural this quarter has tissue biomaterials of partnership for and to -- healthy science to in pursuing for enabling X-dimensional print about part fundamental
bear that emerging we're believe investments now we healthcare, comprises While strong field fruit, role in a over which to and revenue these will take the technology time of partnerships half our Company's to now this well-positioned with are medicine. key in we play establishing, regenerative foundation leadership
this After -- sequentially midst the from X.X% of our seeing having that Company improved linked reflects our and compared We the in industrial to efficiency as last together [Indiscernable] the rebound more QX, continued return exclusively approach. growth we're So to to have of of pursuits, customers plan pandemic. The holistic of and our With organizational view market accelerate economic second friction, turnaround a quarter and rebound a through performance to being and as the sales the industrial of due in launched quarter. the segment our polymer restructuring saw a executed implemented slowdown QX, combined part turnaround segment-oriented X-phase the enhancements we to in additive in range XXXX. industry-leading scale, all internal summarize, efforts. technologies focused have first a in summer, through broadest reorganization a on now reduced These growing metal manufacturing. with continued resulted enhancements of
sold flagship into by Our Transportation machines and Factory improved of evidenced was quarter, segments. is of this Aerospace X which sale model a the Metal XXX the our record
the challenges certain chain the concerns, In our COVID two to we to shortages. good for the of to and into improving growth macroeconomic combined go item, products. components see of conditions, economic and execution see with we supply impact While availability quarters seeing solid including performance, could last costs continue variance from tightening that virus, this have that inflation regards continuing of last new begun
through issues and positive to about second headwind continues move the a team the year. as half, the manage potential see Our but we through we we remain this as
XXXX. The to Even basis, was turn XX.X% the from with continue in stock related charge to are inventory, divestitures, of Now, the of non-GAAP primarily XXXX, an XX%. nonrecurring of quarter XXX the compared for year. the to performance including higher first in profit the Basis the $XX.X XX% second second this increase non-recurring is to to related bonuses of last quarter This XX% the of strong our points. compared primarily by compared for that to sequential quarter year-over-year this higher gross quarter to to XX.X% expenses, compensation and XXXX. for reported non-GAAP second to employee decrease was business. expense million we increase announced gross a a period profit When Operating were XX.X% expenses of of gross in quarter the margin margin. tied XX.X% margin in We profit margins margin we XX% on GAAP This result XXXX. of range gross expect the the compared and to same impacting gross of write-downs year, decreased approximately equipment
to allow we expenses operating invested strategic growth operating quarter first by earlier million corporate revenue slightly $X.X X.X% in the non-GAAP decrease the focus a is of plus $XX.X systems Our revenue investments second operational the as absorb to negative million, support XXXX, growth will X.X% of growth. first operating or to depreciation the and are to and EBITDA of XXXX. the increased adjusted our of made. compared Compared mentioned or to non-GAAP of which the was EBITDA defined second and turns investments X.X% of prior negative infrastructure our quarter margin were quarter second our million year. lower Adjusted the XX.X% infrastructure, quarter our expenses the in better quarter driven Compared profit $XX.X as from to in non-GAAP a future improve people
on $XXX in million were pleased the with QX with Now, acquisition turn our quarter. Cash expenditures decrease generation million. compares quite hand debt of was capital of sheet. by in decreased and and undrawn facility. cash offset $XX.X continued of cash on We $XX.X cash our strong capacity $XXX,XXX We Revolving was full from as This the mentioned million operations, to the million of no ended Credit strong of and million. by Statement driven -- continued favorably to by $XX.X generated $X.X Cash Balance from which XXXX. let's operations cash operations quarter $XX.X costs during primarily Flow used million, This
operating extremely Our cash cost flow. this positive in have strategic enabled turnaround reorganization and management
Before like impact on announced additional business the I divestitures: conclude recently our detail provide Simbionix. and expected Parts X I of On-Demand would my commentary, to the
expect be these in per after to close which contribution revenue will results. per We both which deals, of of generated included margin $XX the $X million businesses basis, and last On planned our non-GAAP combined million of million divestitures, the quarter our mid-third be they a quarter, quarterly a quarter. approximately $X will longer approximately no in to
we driven divestitures will are additive a an exciting like singular fast-growing both when a what accompanied and manufacturing, by From by these worldwide. healthcare will strategic complete? standpoint, focus markets look industrial and be So industry we on
quarter, strongest our third From in customers profile in financial designs industry. financial the to divestitures a customers an we the market-leading the in the will following best-known completion forward broadest our one the of We standpoint, will efficient software of conversion Manufacturing enable of as and of comprehensive finish of Additive printing of to electronic worldwide. large-scale, financial and following standpoint, range From industry. extensive metal and our component materials our largest market-leading technology, the materials -- a suite go providers have polymer metals comprising A platforms Portfolio, for products worldwide.
around million and roughly a profitable Company unique with applications cash approximately including positions of revenue this of with us technology in generation infrastructure, organic expansion and million debt. that well $XXX our profit profile teams, customers strategic new execute support no and exciting EBITDA growth, This industry will be sustainable for our to We're of strong daily also are over. position our balance gross an adjusted are Balance operations and on talents scale, unique from continue of having $XXX we in Manufacturing. to in well-positioned succeed margins invest is growth We an growth, manufacturing outstanding to our of exciting and will the sheet, development, growth profitability, double-digit industry We that technology XX%, this sheet Additive demonstrating very cash opportunities to objective focus, excellent margins to of long-term revenue our reach world that believe with and XX%. in exciting
provide an our have in that Investor to we wanted for Colorado scheduled X the I Finally, Denver, Event update Day area. September on
infections, As many seeing of a rise cases of know, we COVID you in are
